ドライパウダー吸入器のパイプライン - 開発段階、セグメント、地域、規制経路、主要企業

当レポートでは、ドライパウダー吸入器のパイプライン製品について調査分析し、さまざまな開発段階にある製品の比較分析や、進行中の臨床試験のデータを含む、包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

• ドライパウダー吸入器 - パイプライン製品：開発段階別
• ドライパウダー吸入器 - パイプライン製品：地域別
• ドライパウダー吸入器 - パイプライン製品：規制経路別
• ドライパウダー吸入器 - パイプライン製品：推定承認日別
• ドライパウダー吸入器 - 進行中の臨床試験

第4章 ドライパウダー吸入器 - 開発中のパイプライン製品：企業別

• ドライパウダー吸入器企業 - パイプライン製品：開発段階別
• ドライパウダー吸入器 - パイプライン製品：開発段階別

第5章 ドライパウダー吸入器の企業と製品の概要

• Acorda Therapeutics Inc：企業の概要
  • Acorda Therapeutics Inc：パイプライン製品と進行中の臨床試験の概要
• Advent Pharmaceuticals Pty Ltd：企業の概要
  • Advent Pharmaceuticals Pty Ltd：パイプライン製品と進行中の臨床試験の概要
• Aespira Ltd.：企業の概要
  • Aespira Ltd.：パイプライン製品と進行中の臨床試験の概要
• AKELA Pharma Inc.（休止中）：企業の概要
  • AKELA Pharma Inc.（休止中）：パイプライン製品と進行中の臨床試験の概要
• Bayer AG：企業の概要
  • Bayer AG：パイプライン製品と進行中の臨床試験の概要
• Cambridge Healthcare Innovations Ltd：企業の概要
  • Cambridge Healthcare Innovations Ltd：パイプライン製品と進行中の臨床試験の概要
• Creare LLC：企業の概要
  • Creare LLC：パイプライン製品と進行中の臨床試験の概要
• DMK Pharmaceuticals Corp：企業の概要
  • DMK Pharmaceuticals Corp：パイプライン製品と進行中の臨床試験の概要
• Eli Lilly and Co：企業の概要
  • Eli Lilly and Co：パイプライン製品と進行中の臨床試験の概要
• Glenmark Pharmaceuticals Ltd：企業の概要
  • Glenmark Pharmaceuticals Ltd：パイプライン製品と進行中の臨床試験の概要
• GSK plc：企業の概要
  • GSK plc：パイプライン製品と進行中の臨床試験の概要
• Hovione Technology Ltd：企業の概要
  • Hovione Technology Ltd：パイプライン製品と進行中の臨床試験の概要
• Iconovo AB：企業の概要
  • Iconovo AB：パイプライン製品と進行中の臨床試験の概要
• Lupin Pharmaceuticals Inc：企業の概要
  • Lupin Pharmaceuticals Inc：パイプライン製品と進行中の臨床試験の概要
• MannKind Corp：企業の概要
  • MannKind Corp：パイプライン製品と進行中の臨床試験の概要
• Monash University：企業の概要
  • Monash University：パイプライン製品と進行中の臨床試験の概要
• Nektar Therapeutics：企業の概要
  • Nektar Therapeutics：パイプライン製品と進行中の臨床試験の概要
• Ology Bioservices Inc：企業の概要
  • Ology Bioservices Inc：パイプライン製品と進行中の臨床試験の概要
• OPKO Health Inc：企業の概要
  • OPKO Health Inc：パイプライン製品と進行中の臨床試験の概要
• OtiTopic Inc：企業の概要
  • OtiTopic Inc：パイプライン製品と進行中の臨床試験の概要
• Phargentis SA：企業の概要
  • Phargentis SA：パイプライン製品と進行中の臨床試験の概要
• Pharmaxis Ltd：企業の概要
  • Pharmaxis Ltd：パイプライン製品と進行中の臨床試験の概要
• PureIMS BV：企業の概要
  • PureIMS BV：パイプライン製品と進行中の臨床試験の概要
• Quench Medical Inc：企業の概要
  • Quench Medical Inc：パイプライン製品と進行中の臨床試験の概要
• Respira Therapeutics Inc：企業の概要
  • Respira Therapeutics Inc：パイプライン製品と進行中の臨床試験の概要
• Respirent Pharmaceuticals Co Ltd：企業の概要
  • Respirent Pharmaceuticals Co Ltd：パイプライン製品と進行中の臨床試験の概要
• Sandoz International GmbH：企業の概要
  • Sandoz International GmbH：パイプライン製品と進行中の臨床試験の概要
• Sheffield Hallam University：企業の概要
  • Sheffield Hallam University：パイプライン製品と進行中の臨床試験の概要
• Shin Nippon Biomedical Laboratories Ltd：企業の概要
  • Shin Nippon Biomedical Laboratories Ltd：パイプライン製品と進行中の臨床試験の概要
• Spyryx Biosciences Inc（休止中）：企業の概要
  • Spyryx Biosciences Inc（休止中）：パイプライン製品と進行中の臨床試験の概要
• Teva Pharmaceutical Industries Ltd：企業の概要
  • Teva Pharmaceutical Industries Ltd：パイプライン製品と進行中の臨床試験の概要
• Transpire Bio Inc：企業の概要
  • Transpire Bio Inc：パイプライン製品と進行中の臨床試験の概要
• University of Kansas：企業の概要
  • University of Kansas：パイプライン製品と進行中の臨床試験の概要
• University of Sydney：企業の概要
  • University of Sydney：パイプライン製品と進行中の臨床試験の概要
• University of Texas Medical Branch at Galveston：企業の概要
  • University of Texas Medical Branch at Galveston：パイプライン製品と進行中の臨床試験の概要
• Vectura Group Plc：企業の概要
  • Vectura Group Plc：パイプライン製品と進行中の臨床試験の概要
• Verona Pharma Plc：企業の概要
  • Verona Pharma Plc：パイプライン製品と進行中の臨床試験の概要
• Virginia Commonwealth University：企業の概要
  • Virginia Commonwealth University：パイプライン製品と進行中の臨床試験の概要

第6章 ドライパウダー吸入器 - 最近の発展

第7章 付録

List of Tables

List of Tables

• Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
• Dry Powder Inhaler Devices - Pipeline Products by Territory
• Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
• Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date
• Dry Powder Inhaler Devices - Ongoing Clinical Trials
• Dry Powder Inhaler Devices Companies - Pipeline Products by Stage of Development
• Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
• Acorda Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
• INBRIJA - Product Status
• INBRIJA - Product Description
• Acorda Therapeutics Inc - Ongoing Clinical Trials Overview
• INBRIJA - Usability of Levodopa Cyclops Compared to INBRIJA During an Off Episode in Parkinson's Disease Patients
• Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
• g60 Dry Powder Inhaler - Product Status
• g60 Dry Powder Inhaler - Product Description
• Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• resQhaler - Product Status
• resQhaler - Product Description
• AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• Fentanyl TAIFUN Inhaler - Product Status
• Fentanyl TAIFUN Inhaler - Product Description
• Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
• Ciprofloxacin Dry Powder Inhaler - Product Status
• Ciprofloxacin Dry Powder Inhaler - Product Description
• Cambridge Healthcare Innovations Ltd Pipeline Products & Ongoing Clinical Trials Overview
• aeolus Dry-Powder Inhaler (DPI) - Product Status
• aeolus Dry-Powder Inhaler (DPI) - Product Description
• Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
• Intranasal Dry Powder Inhaler - Product Status
• Intranasal Dry Powder Inhaler - Product Description
• DMK Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
• APC-4000 Fluticasone Dry Powder Inhaler - Product Status
• APC-4000 Fluticasone Dry Powder Inhaler - Product Description
• Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
• Nasal Glucagon Delivery System - Product Status
• Nasal Glucagon Delivery System - Product Description
• Glenmark Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
• Tiogiva - Product Status
• Tiogiva - Product Description
• GSK plc Pipeline Products & Ongoing Clinical Trials Overview
• Gemini Multi-Dose Combination Inhaler - Product Status
• Gemini Multi-Dose Combination Inhaler - Product Description
• Hovione Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
• Papillon DPI - Product Status
• Papillon DPI - Product Description
• Iconovo AB Pipeline Products & Ongoing Clinical Trials Overview
• ICOcap - Product Status
• ICOcap - Product Description
• ICOone - Product Status
• ICOone - Product Description
• ICOone - Oxytocin - Product Status
• ICOone - Oxytocin - Product Description
• ICOpre - Product Status
• ICOpre - Product Description
• ICOres - Product Status
• ICOres - Product Description
• Multi-Dose Delivery Device - Product Status
• Multi-Dose Delivery Device - Product Description
• Iconovo AB - Ongoing Clinical Trials Overview
• ICOone - A Feasibility Study with Affilogic for the Development of Inhalable Nanofitin-based Biotherapies
• ICOone - Oxytocin - A Randomized, Single-Center, Partially Single-Blind Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Single and Repeated Doses of Oxytocin Administered via Inhalation or Intravenous or Intramuscular Administration in Healthy Female Participants
• Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
• Dry Powder Inhaler 1 - Product Status
• Dry Powder Inhaler 1 - Product Description
• Dry Powder Inhaler 2 - Product Status
• Dry Powder Inhaler 2 - Product Description
• Tiotropium DPI - Product Status
• Tiotropium DPI - Product Description
• MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
• Afrezza - Pediatric Use - Product Status
• Afrezza - Pediatric Use - Product Description
• Afrezza Inhaler - Product Status
• Afrezza Inhaler - Product Description
• Treprostinil Technosphere - Product Status
• Treprostinil Technosphere - Product Description
• MannKind Corp - Ongoing Clinical Trials Overview
• Afrezza Inhaler - INHALE-3: A 17-Week Randomized Trial and a 13-Week Extension, Evaluating the Efficacy and Safety of Inhaled Insulin (Afrezza) Combined with Insulin Degludec Versus Usual Care in Adults with Type 1 Diabetes
• Monash University Pipeline Products & Ongoing Clinical Trials Overview
• Aerosol Delivery System - Product Status
• Aerosol Delivery System - Product Description
• Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
• NKTR-061 - Product Status
• NKTR-061 - Product Description
• Ology Bioservices Inc Pipeline Products & Ongoing Clinical Trials Overview
• GelVac Intranasal Powder Vaccine Delivery System - Product Status
• GelVac Intranasal Powder Vaccine Delivery System - Product Description
• NanoGENT - Product Status
• NanoGENT - Product Description
• OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
• Inspiromatic - Product Status
• Inspiromatic - Product Description
• OtiTopic Inc Pipeline Products & Ongoing Clinical Trials Overview
• ASPRIHALE - Product Status
• ASPRIHALE - Product Description
• OtiTopic Inc - Ongoing Clinical Trials Overview
• ASPRIHALE - A Phase I, Single-dose, Open-label, Pilot Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Inhalation Powder with Non-enteric-coated Chewable Aspirin in Healthy Adults
• Phargentis SA Pipeline Products & Ongoing Clinical Trials Overview
• Glide DPI - Product Status
• Glide DPI - Product Description
• Indacaterol/Glycopyrronium DPI - Product Status
• Indacaterol/Glycopyrronium DPI - Product Description
• Pharmaxis Ltd Pipeline Products & Ongoing Clinical Trials Overview
• Orbital Dry Powder Inhaler - Product Status
• Orbital Dry Powder Inhaler - Product Description
• PureIMS BV Pipeline Products & Ongoing Clinical Trials Overview
• Amikacin Cyclops - Product Status
• Amikacin Cyclops - Product Description
• Epinephrine Cyclops - Product Status
• Epinephrine Cyclops - Product Description
• Levodopa Cyclops - Product Status
• Levodopa Cyclops - Product Description
• Tobramycin Cyclops - Product Status
• Tobramycin Cyclops - Product Description
• PureIMS BV - Ongoing Clinical Trials Overview
• Levodopa Cyclops - Usability of Levodopa Cyclops Compared to INBRIJA During an Off Episode in Parkinson's Disease Patients
• Quench Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• Dry Powder Inhaler - Product Status
• Dry Powder Inhaler - Product Description
• Glossary

List of Figures

List of Figures

• Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
• Dry Powder Inhaler Devices - Pipeline Products by Territory
• Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
• Dry Powder Inhaler Devices - Pipeline Prod

Abstract

Dry powder inhaler devices deliver medication to the lungs in the form of a dry powder. GlobalData's Medical Devices sector report, "Dry Powder Inhaler Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Dry Powder Inhaler Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Dry Powder Inhaler Devices report provides key information and data related to:

Extensive coverage of the Dry Powder Inhaler Devices under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Dry Powder Inhaler Devices pipeline products.

Review of Recent Developments in the segment / industry

The Dry Powder Inhaler Devices report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Dry Powder Inhaler Devices under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies' revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

• Extensive coverage of the Dry Powder Inhaler Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Dry Powder Inhaler Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Dry Powder Inhaler Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Dry Powder Inhaler Devices Overview

3 Products under Development

• 3.1 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
• 3.2 Dry Powder Inhaler Devices - Pipeline Products by Territory
• 3.3 Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
• 3.4 Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date
• 3.5 Dry Powder Inhaler Devices - Ongoing Clinical Trials

4 Dry Powder Inhaler Devices - Pipeline Products under Development by Companies

• 4.1 Dry Powder Inhaler Devices Companies - Pipeline Products by Stage of Development
• 4.2 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development

5 Dry Powder Inhaler Devices Companies and Product Overview

• 5.1 Acorda Therapeutics Inc Company Overview
  • 5.1.1 Acorda Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Advent Pharmaceuticals Pty Ltd Company Overview
  • 5.2.1 Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Aespira Ltd. Company Overview
  • 5.3.1 Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 AKELA Pharma Inc. (Inactive) Company Overview
  • 5.4.1 AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Bayer AG Company Overview
  • 5.5.1 Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Cambridge Healthcare Innovations Ltd Company Overview
  • 5.6.1 Cambridge Healthcare Innovations Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Creare LLC Company Overview
  • 5.7.1 Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 DMK Pharmaceuticals Corp Company Overview
  • 5.8.1 DMK Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Eli Lilly and Co Company Overview
  • 5.9.1 Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Glenmark Pharmaceuticals Ltd Company Overview
  • 5.10.1 Glenmark Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 GSK plc Company Overview
  • 5.11.1 GSK plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Hovione Technology Ltd Company Overview
  • 5.12.1 Hovione Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Iconovo AB Company Overview
  • 5.13.1 Iconovo AB Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Lupin Pharmaceuticals Inc Company Overview
  • 5.14.1 Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 MannKind Corp Company Overview
  • 5.15.1 MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Monash University Company Overview
  • 5.16.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Nektar Therapeutics Company Overview
  • 5.17.1 Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Ology Bioservices Inc Company Overview
  • 5.18.1 Ology Bioservices Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 OPKO Health Inc Company Overview
  • 5.19.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 OtiTopic Inc Company Overview
  • 5.20.1 OtiTopic Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 Phargentis SA Company Overview
  • 5.21.1 Phargentis SA Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 Pharmaxis Ltd Company Overview
  • 5.22.1 Pharmaxis Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 PureIMS BV Company Overview
  • 5.23.1 PureIMS BV Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 Quench Medical Inc Company Overview
  • 5.24.1 Quench Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.25 Respira Therapeutics Inc Company Overview
  • 5.25.1 Respira Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.26 Respirent Pharmaceuticals Co Ltd Company Overview
  • 5.26.1 Respirent Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.27 Sandoz International GmbH Company Overview
  • 5.27.1 Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.28 Sheffield Hallam University Company Overview
  • 5.28.1 Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview
• 5.29 Shin Nippon Biomedical Laboratories Ltd Company Overview
  • 5.29.1 Shin Nippon Biomedical Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.30 Spyryx Biosciences Inc (Inactive) Company Overview
  • 5.30.1 Spyryx Biosciences Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.31 Teva Pharmaceutical Industries Ltd Company Overview
  • 5.31.1 Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.32 Transpire Bio Inc Company Overview
  • 5.32.1 Transpire Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.33 University of Kansas Company Overview
  • 5.33.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
• 5.34 University of Sydney Company Overview
  • 5.34.1 University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
• 5.35 University of Texas Medical Branch at Galveston Company Overview
  • 5.35.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
• 5.36 Vectura Group Plc Company Overview
  • 5.36.1 Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.37 Verona Pharma Plc Company Overview
  • 5.37.1 Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.38 Virginia Commonwealth University Company Overview
  • 5.38.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview

6 Dry Powder Inhaler Devices- Recent Developments

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer